Santander Group finances Lorca Solar project with contracts from Haleon and GSK
What happened
Santander Group financed the Lorca Solar project, a €335 million investment located in Lorca, Spain. The project secured long-term power purchase agreements (PPAs) with Haleon, GSK, Thermo Fisher Scientific, and The Sherwin-Williams Company. The solar farm is designed to generate approximately 683,374 MWh of clean energy annually.
Why it matters
The project contributes to renewable energy capacity in Spain. Furthermore, the construction involved the employment of over 2,100 professionals and participation from more than 80 small and medium-sized enterprises in the surrounding area.
A solar farm was inaugurated in Lorca, a municipality in the Region of Murcia, Spain.
Who's involved
- Santander GroupFinanced the Lorca Solar project alongside Instituto de Crédito Oficial and Unicaja.
- HaleonSecured a long-term power contract under the project's PPAs.
- GSKSecured a long-term power contract under the project's PPAs.
- LorcaIs the municipality where the solar project is located.
- MurciaIs the region of Spain where the solar project is located.
Who could feel it
Possible knock-on effectsThese are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.
- HaleonSpeculative
Could reduce operational energy costs by securing a long-term power purchase agreement.
- GSKSpeculative
Could reduce operational energy costs by securing a long-term power purchase agreement.
- MurciaSpeculative
May see local investment and job creation due to the €335 million project.
- LorcaSpeculative
May see local investment and job creation due to the project location.
- Santander GroupSpeculative
May benefit from the successful deployment of its €335 million financing for a renewable project.
- SpainSpeculative
Could contribute to national renewable energy capacity goals.
Keep exploring
The entities involved
-
Santander Group
Spanish multinational company
-
Haleon
British multinational consumer healthcare company
Nothing else this week.
-
GSK
British multinational pharmaceutical and biotechnology company